First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing (original) (raw)

First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing

Argyro Syngelaki

Fetal diagnosis and therapy, 2014

View PDFchevron_right

Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening

Kevin Spencer, Stefano Faiola

Ultrasound in Obstetrics and Gynecology, 2005

View PDFchevron_right

Prospective validation of first-trimester combined screening for trisomy 21

Adolfo Etchegaray

Ultrasound in Obstetrics and Gynecology, 2009

View PDFchevron_right

First trimester contingent screening for trisomies 21,18,13: is this model cost efficient and feasible in public health system?

enrico periti

Journal of Maternal-fetal & Neonatal Medicine, 2017

View PDFchevron_right

Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies

Kevin Spencer

American Journal of Obstetrics and Gynecology, 2005

View PDFchevron_right

First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation

Isabelle Czerkiewicz

Ultrasound in Obstetrics and Gynecology

View PDFchevron_right

First-trimester screening for trisomy 21 with adjustment for biochemical results of previous pregnancies

Argyro Syngelaki

Fetal diagnosis and therapy, 2011

View PDFchevron_right

Prospective study evaluating performance of first‐trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP‐A and free β‐hCG

Pernille Nørgaard

Ultrasound in Obstetrics & Gynecology, 2012

View PDFchevron_right

First-trimester screening for trisomy 21 using alpha-fetoprotein

Argyro Syngelaki

Fetal diagnosis and therapy, 2011

View PDFchevron_right

Single-Step Maternal Serum Screening for Trisomy 21 in the Era of Combined or Integrated Screening

Annie Vereecken

Gynecologic and Obstetric Investigation, 2004

View PDFchevron_right

Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks

Olav Petersen

Prenatal Diagnosis, 2008

View PDFchevron_right

First Trimester Biochemical Screening for Trisomy 21

Tim Reynolds

Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, 1995

View PDFchevron_right

Screening for Trisomy 21 with Maternal Age, Fetal Nuchal Translucency and Maternal Serum Biochemistry at 11–14 Weeks: A Regional Experience from Germany

Alexander Scharf

Fetal Diagnosis and Therapy, 2006

View PDFchevron_right

Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks

Gergő Orosz

Ultrasound in Obstetrics & Gynecology, 2014

View PDFchevron_right

Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing

Jader De Jesus Cruz, Ismini Staboulidou

Ultrasound in Obstetrics and Gynecology, 2010

View PDFchevron_right

First-trimester combined screening for trisomy 21 at 8-13 weeks

Daljit Sahota

… in obstetrics & …, 2010

View PDFchevron_right

First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study

Vicenç Cararach, Elena Casals

Prenatal Diagnosis, 2004

View PDFchevron_right

One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies

Kevin Spencer

Ultrasound in Obstetrics and Gynecology, 2002

View PDFchevron_right

Influence of first trimester biochemistry methodology on detection rate in screening for trisomy 21

Dariusz Borowski

Ginekologia Polska, 2017

View PDFchevron_right

Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21

Norbert Winer

JAMA

View PDFchevron_right

Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing

Jan Dickinson

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2017

View PDFchevron_right

Screening for fetal trisomy 21 in gestational weeks 6 and 7

Olav Petersen

Acta Obstetricia et Gynecologica Scandinavica, 2010

View PDFchevron_right

Rapid non-invasive prenatal screening test for trisomy 21 based on digital droplet PCR

Marie Korabecna

Scientific Reports, 2023

View PDFchevron_right

First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies

rdeci knof

Genetics and Etiology of Down Syndrome, 2011

View PDFchevron_right

First-Trimester Screening for Trisomies 21 and 18

Naomi Greene

New England Journal of Medicine, 2003

View PDFchevron_right

Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more

Francesca Ravennati

Journal of Maternal-Fetal and Neonatal Medicine, 2014

View PDFchevron_right

Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies

Pierangela Biasio

Journal of Maternal-Fetal and Neonatal Medicine, 2009

View PDFchevron_right

First-Trimester Screening for Trisomy 21 by Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A: Impact of Maternal and Pregnancy Characteristics

Kevin Spencer

Obstetrical & Gynecological Survey, 2008

View PDFchevron_right

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study

Tak Leung

BMJ, 2011

View PDFchevron_right